Add Yahoo as a preferred source to see more of our stories on Google. CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. (T.

CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.

After a record quarter, CMR closes the year with a Versius global install base more than 50% higher than 2022 Over 17,000 surgical procedures completed using Versius, representing a procedural growth ...

Cambridge, United Kingdom. 20 September 2023 0700 (BST). CMR Surgical (CMR or ‘the Company’) – the global surgical robotics business – has today announced that its next-generation Versius ® Surgical ...

CMR Surgical won Food and Drug Administration authorization for its Versius robot with an initial indication for gallbladder removal surgery. CMR will partner with select hospitals as the first part ...

insights from industryMark SlackChief Medical OfficerCMR Surgical In this interview, we speak to Mark Slack, Chief Medical Officer at CMR Surgical, about their next-generation surgical robot Versius ...

CMR Surgical launches vLimeLite * a new imaging technology to visualise ICG, the first product launch in a series of 2024 product releases as part of Versius Plus, a significant enhancement to the ...

Add Yahoo as a preferred source to see more of our stories on Google. CMR Surgical is based in Cambridge, United Kingdom. (Courtesy of CMR Surgical) This story was originally published on MedTech Dive ...

Cambridge, England-based CMR Surgical said it has received FDA 510(k) clearance for Versius Plus, its second-generation surgical robotic platform. The clearance covers cholecystectomy procedures, also ...

PHOENIX, April 2, 2025 /PRNewswire/ -- Trinity Capital Inc. (TRIN) (NASDAQ: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of up to $68.75 million in growth ...